School of Pharmacy researchers Professor David Mott and Aaron Gilson examine the barriers and benefits of community pharmacists gaining access to patients’ health histories.
Research
Weiping Tang Receives NIH Grant for Coronavirus Research
Here are 3 things to know about the Tang Lab’s work toward antiviral therapeutics targeting a broad range of coronaviruses.
New Effective and Safe Antifungal Isolated From Sea Squirt Microbiome
By combing the ocean for antimicrobials, scientists at the University of Wisconsin–Madison have discovered a new antifungal compound that efficiently targets multi-drug-resistant strains of deadly fungi without toxic side effects in mice.
Secret Cover Star
Sally Griffith-Oh helps explain science through illustrations with 19 published journal covers Conveying complex scientific concepts visually is not for the faint of heart. But for Sally Griffith-Oh, Information Processing Consultant in the Instructional and …
New Henrichs Chair Enhances Pharmaceutical Sciences Research
Professor Seungpyo Hong is the Chair’s first recipient, adding to a growing roster of alumni-supported professorships By Katie Ginder-Vogel The oldest son of dairy farmers, Milton Henrichs (BS ‘44) grew up north of Green Bay, …
Breaking Down Barriers to Substance Abuse Treatment
School of Pharmacy researchers illuminate and address pharmacists’ barriers to providing naltrexone injections for substance abuse treatment.
Degraders: A New Drug Discovery Approach
Professor Weiping Tang harnesses cells’ natural protein disposal system to destroy disease-causing proteins.
Record Number of Pharmacology and Toxicology Students Earn Hilldale Fellowship
The prestigious campus award is funding Pharmacology and Toxicology student research into cancer, aging, and plant growth.
New NSF Grant Will Improve Synthesis of Bacterial Carbohydrates
The support from the National Science Foundation will help Professor Weiping Tang develop novel chemical methods to synthesize bacterial carbohydrates for studies of biology and disease.
Academia to Industry
Soon after graduation, Tony Tam (PhD ’18) advances drug development and formulation at Merck.